Archive for the Abortion Pill Connections Category

Who is footing the bill for ‘free’ abortion pills on California college campuses?

Posted in Abortion Pill Connections, Abortion Pill Horrors, Abortion Pills Campus, Buffett Foundation, California abortion stats, DANCO, self-managed abortion, Songs, TARA Health Foundation, Women’s Foundation of California with tags , , , , , , , , , , , , , , , , , , , , , , , on October 20, 2019 by saynsumthn

abortion pill

A measure to force public universities to offer dangerous abortion pills on college campus, recently signed into law by California Governor Gavin Newsom, will initially be set up using funds from pro-abortion groups. However, pro-life student group Students for Life of America (SFLA) notes that student fees will also be used to fund on-campus abortions, since those fees underwrite the costs of campus healthcare centers. SFLA also pointed out how the conscience rights of students and healthcare workers will be violated if forced to participate with abortions. “This law includes funds that can go to Planned Parenthood for ‘consulting’ and new funds for ‘security’, allowing the nation’s number one abortion vendor to sit back and cash checks, enjoying the chaos of abortions taking place at schools without any of the risk,” said SFLA president Kristin Hawkins.

The bill requires student health care services centers at the state’s 34 University of California (UC) and California State University (CSU) campuses to offer medication abortion on and after January 1, 2023. According to a Department of Financial Bill Analysis, SB 24 “establishes the College Student Health Center Sexual and Reproductive Health Preparation Fund under the administration of the Commission on the Status of Women and Girls.” It requires the Commission, whose current chair Alisha Wilkins previously worked for Planned Parenthood of the Pacific Southwest in Riverside, “to provide grants of $200,000 to each student health center, and a grant of $200,000 to both the UC and CSU system to become prepared to offer abortion by medication techniques and develop associated back-up medical supports.”

The abortion pill was brought into the U.S. by the Population Council, a eugenics organization which sought out investors to set up a highly secretive company — DANCO Laboratories — to manufacture the drug.

Investors included:

  • The Packard Foundation, which originally invested in 1996 to help keep DANCO afloat when it “ran short on funds”
  • The Buffett Foundation, identified by the Washington Post in 2000, writing, “The Buffett Foundation… made at least $2 million in interest-free loans to the Population Council… according to tax documents filed in 1995. That money was in turn used to conduct clinical trials of RU-486 [the abortion pill].”
  • George Soros (Open Society Foundations)
  • A number of other abortion pill investors chose to remain unnamed, according to internal documents reviewed by the Wall Street Journal
Packard Timeline shows it invested in abortion pill distributor

Packard Timeline shows it invested in abortion pill distributor

 

To update campus student health center procedures, provide training, and purchase equipment at UC, the Department’s analysis estimated:

  • One-time system wide readiness General Fund costs between $4.6 million to $7.8 million…
  • Ongoing General Fund costs of $2.2 million to $3.3 million commencing in 2023 to provide abortion by medication services in each campus student health center and provide access to 24-hour telehealth services.

At CSU, the initial costs were “unknown” but raised concerns it could likely range in the millions to low tens of millions of dollars.

Image: CSU on costs of law mandating abortion pills on California campuses (Image: CBS Sacramento)

CSU on costs of law mandating abortion pills on California campuses (Image: CBS Sacramento)

“While this bill and its sponsors indicate that private financing would cover all the costs associated with this bill, Finance notes this bill could create future General Fund cost pressures to the extent sufficient private funding cannot be raised to support readiness grants, the costs to comply with this bill’s requirements exceed the proposed grant funding, or to the extent the UC and CSU incur ongoing costs after January 1, 2023,” the analysis said.

zImage: Lila Rose on law mandating abortion pills on California campus (Image: Twitter)

Lila Rose on law mandating abortion pills on California campus (Image: Twitter)

According to a statement by the ACLU, a “[C]onsortium of funders, including the Women’s Foundation of California and Tara Health Foundation,” has raised the initial funds.

Tara Health Foundation (THF):

Image: TARA Health Foundation promotes abortion

TARA Health Foundation promotes abortion

The Women’s Foundation of California:

According to the Guttmacher Institute there were 132,680 abortions committed in California in 2017. A previous analysis by Live Action News revealed that taxpayers in the state paid over half a billion dollars (nearly $700 million) for abortions from 1989 to 2014. In 2017, the pro-abortion Advancing New Standards in Reproductive Health (ANSIRH) — a research group at the University of California, San Francisco (UCSF)’s Bixby Center for Global Reproductive Health, which trains abortion providers — estimated, “Approximately 23% of CSU students and 12% of UC students are enrolled in Medi-Cal.”

Image: Medi-Cal FFS abortion expenditures in California 1989 to 2014 (Image: Live Action News)

Medi-Cal FFS abortion expenditures in California 1989 to 2014 (Image: Live Action News)

“Students across UC and CSU campuses obtain 1,038 abortions each month,” ANSIRH wrote adding, “[W]e estimate there would be between 322-519 medication abortions occurring across UC and CSU campuses every month.”

SFLA claims there was no need for the law because abortion facilities are less than 6 miles from every California public university and college campus. The group also claims there are no safeguards are in place to protect women who may be dosed with the drugs without their consent. Live Action News previously documented how many of those behind the push for these dangerous pills to be readily available on campus are also pushing for FDA safety requirements to be lifted. To date, at least 24 women have died from the abortion pill and literally thousands have been hospitalized with serious complications.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Abortion Weaponization Playbook: strategy to enshrine and expand abortion in America

Posted in Abortion Pill Connections, ANSIRH, expand abortion, Guttmacher, Gynuity, Hollywood, Hyde Amendment, Pro-choice Strategy, RHA, Self Managed Abortion, self-managed abortion, Tax Payer Funding of Abortion, Teen Abortion, Teen Pregnancy with tags , , , , , , , , , , , , , , , , , , , , , , , on June 8, 2019 by saynsumthn
When Planned Parenthood and the media claim “abortion laws” are part of a long held strategy to dismantle Roe and ban abortion- as demonstrated in these Tweets….remind them that it is the abortion lobby that has had a long held strategy to weaponize abortion, as I will demonstrate below.

REMIND them that the abortion lobby and Planned Parenthood want to WEAPONIZE abortion and there has been a strategy to expand abortion: 

#1) Click to READ: EXPOSED: Abortion groups’ plan to ‘increase supply and demand’ for abortion   

A 92-page report on the Tara Health Foundation website should be reviewed by pro-life advocates across the nation, as it details upcoming strategy from abortion supporters, which includes the push for “home use” abortions. The document, as detailed at Live Action News reveals pro-abortion legislative and litigation strategies suggested in the report include:

  • REMS removal strategy (This is the risk management system that governs the abortion pill RU486)
  • TRAP laws removal advocacy
  • Gestational bans removal advocacy
  • Criminality of self-induced abortion removal advocacy
  • Organizing led by women of color (WOC)
  • Reproductive health or democracy reform PAC donations
  • Reproductive justice PAC donations
  • The plan committed to “increasing access for people with low incomes” even “where abortion… becomes inaccessible or is banned completely.”

TARA Health Foundation Abortion strategy

 

#2). Click to Read: Planned Parenthood’s 3-part plan for 2019: Abortion, Abortion, Abortion 

This Live Action News piece, documents that earlier this year, Planned Parenthood released its plan for 2019, and despite  declining clients and health services, the plan reveals the organization’s continued obsession with abortion. The “multi-million dollar” plan was announced by the group’s political advocacy arm, Live Action News reports.
According to PP’s document and the Live Action News article, the largest provider of abortion planned to do the following:

Expand abortion using a Regional Access Network the abortion chain’s plans include:

  • A Regional Access Network anywhere abortion either becomes inaccessible or is banned completely
  • Facilitate telehealth care and transportation for patients facing obstacles to abortion
  • Opening new abortion facilities
  • Expanding medication abortion services
  • Expanding telemedicine services to increase abortion access for clients in remote communities

Legislative efforts to expand tax funded abortion, the plan will target 10 states, including:

  • Illinois, where Planned Parenthood is pushing public funding of abortion and ways the state can “codify the right to abortion in state law”
  • Maine, where Planned Parenthood is “moving to ensure women insured through public programs can have… abortion”
  • Rhode Island. where Planned Parenthood “will work in the 2019 legislative session to codify the right to…abortion in state law”
  • Oregon, where Planned Parenthood “is implementing the Reproductive Health Equity Act to guarantees no-cost coverage for… abortion”
  • Hawaii, where Planned Parenthood “is working to expand access to…abortion by advancing comprehensive coverage of… abortion”
  • Washington, where Planned Parenthood “is focusing on passing the Reproductive Health Equity Access bill” to remove barriers to abortion

Use Hollywood and media to “destigmatize abortion” the plan vows to:

  • Work with “content creators” on portraying abortion positively in film and television
  • Create resources to encourage, “accurate, non-judgmental conversations about abortion…”
  • Use technology to “help people understand the reality of safe, legal abortion and what patients experience when having an abortion”

#3) Click to Read Guttmacher Institute releases plan to expand abortion in 7 ways 

Live Action News documents how, the Guttmacher Institute, Planned Parenthood’s former “special affiliate,” has published a new “policy review,” titled, “Ensuring Access to Abortion at the State Level.
The document is broken down by several strategy subjects:
  • Affirming and Protecting the Right to Abortion
  • Providing Abortion Coverage
  • Ensuring Access to Information
  • Supporting Adolescents’ Access
  • Preventing Clinic Violence
  • Expanding the Pool of Abortion Providers
  • Creating a Safe Policy Environment for Self-Managed Care
  • Expanding Online and Telehealth Access

Paraphrased by Live Action News as follows:

  • 1) Push statutory and constitutional measures to codify abortion
  • 2) Increase taxpayer-funded abortion
  • 3) Force insurance companies to cover abortion
  • 4) Eliminate informed consent 
  • 5) Increase abortion customers
  • 6) Allow non-physicians to commit abortions
  • 7) Push “self-managed abortions”

#4) Advancing New Standards in Reproductive Health (ANSIRH), Gynuity Health Projects, and Ibis Reproductive Health  

According to another Live Action News report, “A consortium of abortion organizations — Advancing New Standards in Reproductive Health (ANSIRH), Gynuity Health Projects, and Ibis Reproductive Health — published a report entitled, “A roadmap for research on self-managed abortion in the United States.” The report suggested, [M]edication abortion could be even further demedicalized through pharmacy dispensing and expansion of telemedicine models—or even making it available over the counter (OTC)—which have the potential to expand access greatly.”

And…what do you know? Abortion organizations are pushing to expand abortion like never before, by attempting to influence the FDA to remove important safety regulations, called REMS which will enable them to sell the dangerous abortion pills online.

The Document claims these groups are planning to: 

  • Expand direct-to-patient telemedicine with various options, such as:
  • Use of phone rather than videoconferencing. 
  • Web-based interface for patient interactions and for recording clinical and research data.
  • Provision of medication abortion pills from a central pharmacy rather than from each clinician’s office.
  • Elimination of the requirement for screening ultrasound and lab tests (i.e., implement screening based entirely on history).
  • Home-based follow-up methods using urine pregnancy testing.
  • Study the uptake, safety, and effectiveness of advance provision of medication abortion pills.
  • Undertake an OTC label comprehension study and develop and implement an actual use study in a simulated OTC environment.
  • Identify ways to improve access in legally restricted settings using data from research with online providers and smartphone apps.

All pro-life groups need to read the abortion weaponization playbooks outlines above.

SHARE THIS Article!

 

Group vows to defy FDA, continues dispensing abortion pills illegally

Posted in Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, Abortion Pills Illegal, DANCO, FDA, Illegal abortion, Population Control with tags , , , , , , , , on June 1, 2019 by saynsumthn

abortion pill

Just days after 100 lawmakers sent a letter to the Food and Drug Administration (FDA) — which oversees drug safety — requesting that the FDA monitor abortion group Aid Access for illegally dispensing abortion pills, Aid Access announced its intent to defy the FDA’s warnings to “immediately cease” dispension of the drugs.

Aid Access founder Rebecca Gomperts published her response on Aid Access’s website as well as on Women on Waves, another organization Gomperts founded in 1999. Gomperts claims, “Last year, I prescribed 2,581 medical abortions out of 11,108 women who consulted me.”

Gomperts states in part:

On March 8, 2019, I received a letter from the FDA ordering my new (since 2018) organization, Aid Access, to stop providing telemedical abortion services to women who cannot otherwise access safe abortions because of costs, domestic violence, distance, or other reasons, and who do not have access to other doctors willing or able to prescribe misoprostol and mifepristone.

This letter was applauded by Republican members of Congress, of whom 92 percent are male.

But I will not be deterred. When U.S. women seeking to terminate their pregnancies prior to 9 weeks consult me, I will not turn them away. I will continue to protect the human and constitutional right of my patients to access safe abortion services.

Notably, the Congressional letter was signed by a number of women in Congress, including Reps. Martha Roby, Carol D. Miller, Virginia Foxx, Liz Cheney, Ann Wagner, Jenniffer González Colón, Debbie Lesko, and several medical doctors who also serve in the House of Representatives, among many others.

Rebecca Gomperts founder of Aid Access defiant to offer illegal abortion pills online

In a statement to Live Action News, the FDA wrote:

As noted in the FDA warning letter to AidAccess issued on March 8, 2019, failure to correct the violations of the law may result in FDA regulatory action, including seizure or injunction, without further notice. We cannot comment on a potential future action at this time, but we remain very concerned about the sale of unapproved mifepristone for medical termination of early pregnancy on the Internet, because this bypasses important safeguards designed to protect women’s health. Unapproved drugs purchased from foreign internet sources are not the FDA-approved versions of the drugs, and therefore, they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities. Drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.

The statement went on to say that “The FDA’s regulation and oversight of the drug approval process and drug distribution helps to protect patients by applying rigorous scientific and safety standards, requiring labeling review for accuracy and completeness, and working to ensure that counterfeit and unsafe medicines do not enter the U.S. drug supply. When these requirements are not met, FDA can step in to help protect consumers.” The FDA reiterated that it has warned AidAccess.org and Rablon that they are in violation of the Federal Food, Drug, and Cosmetic Act for causing the introduction of unapproved new drugs into U.S. commerce.

Drugs are tightly regulated by the FDA for a reason, and under current requirements, the abortion pill — also known as Mifeprex or Mifepristone — is only permitted to be dispensed in hospitals or clinics by medical personal who are approved prescribers of the pill. FDA placed Mifeprex under a tighter regulatory system known by the acronym REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The FDA has warned women against purchasing these dangerous pills online: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

READ: AWFUL: Abortion groups tell women to lie about abortion pill, claim miscarriage

Weeks ago, the FDA updated its adverse events report through 2018, documenting “24 deaths of women associated with Mifeprex since the product was approved in September 2000….” The FDA also noted at least 4,200 additional adverse effects. Under 2016 changes, the drug’s manufacturer, Dancono longer has to report non-fatal adverse effects, so we can only imagine what the number really is.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

Live Action News previously documented a larger push by pro-abortion organizations to lift the FDA’s REMS requirements, to expand abortion pill dispension to mail order and online sales, via self-managed abortions. And we also documented the secretive history of Danco’s investors, which include organizations such as the Packard Foundation and other abortion philanthropists, who appear to stand to gain financially from a broad abortion pill expansion. The original drug, Mifeprex, was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council.

The defiance by Aid Access comes on the heels of multiple pro-life bills being passed in several states. Pro-abortion organizations, who used to claim that self-abortions injure and even kill women, now appear willing to place them in harm’s way. In addition, when these same women experience serious complications from these dangerous pills, they are instructed to present to the ER and lie, claiming they had a miscarriage. Ironically, while the abortion lobby shows support to Aid Access, they simultaneously want to discredit the science behind abortion pill reversal.

Editor’s Note 5/17/19: This article was edited to include a statement from the FDA.

  • This article is reprinted with permission. The original appeared here at Live Action News.

Taxpayers send millions to abortion training program at UCSF

Posted in Abortion Pill Connections, Abortion Pill Study, Abortionist, Abortionist Training, Bill Gates, Fellowship in Family Planning (FFP), Hewlett Foundation, Innovating Education in Reproductive Health, National Abortion Federation, Packard Foundation, Philip Darney, Ryan Residency, Uta Landy with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

Who’s paying millions for this abortion training program? Taxpayers.

third trimester abortion, abortion training

Abortion training is being orchestrated out of a University of California, San Francisco (UCSF) program which receives millions in government dollars. UCSF trains abortion providers through their Bixby Center for Global Reproductive Health , which claims to be “one of the few research institutions to unflinchingly address abortion, investigating multidimensional aspects of abortion care in the United States and globally.” Bixby claims their work has:

According to Bixby’s annual reports, in 2014, nearly $22 million dollars (52 percent) of Bixby’s revenue came from the taxpayer, although the report does not specify whether the funds were state or federal. By 2015, although Government dollars made up only 18 percent of Bixby’s revenue, it totaled over $18 million in taxpayer dollars. Bixby is conveniently located in California, which permits millions in taxpayer dollars to fund abortions and has no requirement that abortion numbers be reported to the Centers for Disease Control (CDC) for data analysis.

UCSF Bixby Gov Funding 18 million in 2015 to 2016 AR

Taxpayer dollars sent to UCSF for fetal research include millions from the National Institutes of Health (NIH). A recent report published by CNS News breaks down the dollars of the multi-year contract:

[T]he Department of Health and Human Services has granted contracts to UCSF to make “humanized mice.”… According to contract information published on the Federal Procurement Data System, the new three-month extension will pay UCSF $521,082—bringing the total payments the federal government has made to UCSF for this contract to $10,596,960. If the government continues renewing the contract through Dec. 5, 2020, HHS would end up paying UCSF a total of $13,799,501.

In addition to government (taxpayer) dollars, Bixby receives funding from a number of organizations collaborating to expand abortion, such as:

UCSG Bixby trains abortion to increase access (Image: Twitter)

According to Bixby, which was created to address a shortage of abortionists dating back to the mid 1980’s, the number of US abortion providers decreased by 38% between 1982 and 2005, and some 87% of US counties do not have an abortion provider.

Bixby runs two flagship programs, which “provide the opportunity to develop high-level research and clinical skills in abortion and contraception:”

FFP was established by Dr. Philip Darney, and as previously reported, FFP’s website makes it clear that abortion is their mission, stating that the family planning fellowship is a “two-year fellowship focused on subspecialist training in research, teaching and clinical practice in abortion and contraception… and they play an active role in discussions in the media related to family planning access and advocate for their patients in popular media outlets.”

Fellowship in Family Planning FFP FB Page (Image credit: Facebook)

Live Action News also previously reported how the Kenneth J. Ryan Residency Training Program in Abortion and Family Planning was founded in 1999 by Dr. Uta Landy, a former director of the National Abortion Federation and a recipient of Planned Parenthood Federation of America’s infamous Margaret Sanger Award. According to the Bixby Center, Landy established “one of the first abortion clinics in New York after legalization in 1970, and became the first executive director of the National Abortion Federation in 1979.” Landy was recently caught in undercover footage from the Center for Medical Progress talking about late-term abortions.

Philip Darney and Uta Landy at UCSF abortion training

The Ryan program is now at 70 major medical schools in the US and Canada, according to their website.

The Bixby Center was originally founded as the Center for Reproductive Health Research & Policy in 1999 by Philip Darney, MD and Nancy Padian, who were shortly thereafter joined by Claire Brindis, DrPH, MPH, and Felicia Stewart, MD, according to their report. The Center offers online abortion training courses and lectures through its Innovating Education in Reproductive Health which is described as “a digital hub that highlights innovative family planning and abortion curricula, tools, teaching techniques and research from educational leaders around the world.”

Innovating Education at UCSF abortion training

The group’s week by week abortion course, “Abortion Quality Care and Public Health Implications,” has a stated goal to destigmitize abortion, among other things. The “career planning brochure” instructs graduates to “moonlight” at abortion facilities and to “highlight [their] abortion training as a special skill set” when they apply to a practice.

Innovating Education Abortion Career Planning Brochure

The abortion training course is introduced by Jody Steinauer, Associate Professor at UCSF. The course is “directed at health care students and professionals.”

The video lectures lead up to the topic of  “abortion after the first trimester,” in week four, where Steinauer admits that later abortions “can be a difficult topic to discuss for many due to feelings about a more developed fetus.”

Jody Steinauer at UCSF abortion training

Despite the abortion industry’s frequent denial of facts about fetal development, Bixby’s TEACH Program (Training Early Abortion for Comprehensive Healthcare) workbook acknowledges that the fetal heartbeat can be detected very early, around six weeks gestation (dates used are gestational, which is measured at two weeks more than the date of fertilization):

The embryo follows a predictable path of development and therefore can be used to date a pregnancy based on its size. The embryo appears at approximately 6 weeks and grows 1 mm per day thereafter until 12-14 weeks. After 12 weeks, fetal flexion and extension make measuring length more challenging and using the fetal biparietal diameter (BPD) is preferred. Cardiac activity appears around 6 ½ weeks.

Bixby abortion training workbook TEACH

The workbook then gives suggestions on how to speak to an abortion patient about the baby. But because this is about ending the life of a developing human person in the womb, the workbook suggests abortion providers use euphemisms like “pregnancy” instead of scientifically correct terminology such as fetus or baby.

“Your pregnancy is 8 weeks along,” instead of  “Your baby is 8 weeks old.”

Bixby abortion training workbook TEACH communication

In upcoming Live Action News articles, we will highlight various teaching lectures published by the UCSF abortion training program.

    • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Media ignores profit motive of researcher attempting to discredit abortion pill reversal

Posted in Abortion pill, Abortion Pill Connections, Abortion Pill Study, Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Clinical Trial APR, Contraception Journal, DANCO, Daniel Grossman, Mitchell D. Creinin, Population Council, Reproductive Health Professionals (ARHP), RU-486, University o California San Francisco (UCSF), University of California, University of California Davis with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

abortion pill birth control

 

The principal investigator of a study seeking to disprove the legitimacy of abortion pill reversal has direct ties — including financial ties — to abortion pill manufacturer Danco, which was formed by the eugenics-founded Population Council. This potential conflict of interest should demand scrutiny from the media — but instead, the media willingly questions abortion pill reversal based upon a single “expert” that receives compensation from Danco. This “expert” is Mitchell D. Creinin, a professor at University of California, Davis, sponsor of the study.

Mitchell Creinin has long history with abortion. He is an abortionist who was involved in clinical trials of RU-486 at Magee-Women’s Hospital Dept. of OB/GYN Pittsburgh, PA. He was the previous medical and lab director of Planned Parenthood of Western Pennsylvania, as described by Oxford University Press. He worked on an abortion training publication for the National Abortion Federation (NAF). He has served on the Board of Directors for the Association for Reproductive Health Professionals (ARHP). He is also listed among the advisory counsel for the early abortion training guide published by Advancing New Standards in Reproductive Health (ANSIRH), part of UCSF’s Bixby Center for Global Reproductive Health.

As I detailed in a Twitter thread shown below, Creinin’s abortion history and connections to the abortion pill’s manufacturer are deep and worth mentioning. This calls into question the validity of his study into abortion pill reversal. Creinin has financial incentive to make sure the abortion pill remains in demand, as do the study’s sponsors. This is a blatant conflict of interest.

Carole Novielli@CaroleNovielli

Person behind “Clinical Trial” to attempt to disprove abortion pill reversal (APR) – connected to abortion and takes money from abortion pill manufacturer- can you say CONFLICT? https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

 

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

3/ Mitchell D Creinin is Professor at University of California, Davis (UCD) – the anti-APR study’s sponsor more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/ceovZv7Uqr

See Carole Novielli’s other Tweets
View image on Twitter

Carole Novielli@CaroleNovielli

4/ Mitchell D Creinin is a consultant for abortion pill manufacturer, receiving consulting fees $$/ honorarium f/ DANCO https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/GZ4s3kfmSp

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

5/ Mitchell D Creinin provided “third-party telephone consults,” for pill (Mifeprex or RU486) DANCO – formed by Population Council
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/MsAH2mXW7v

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

6/ Creinin founding member of Society of Family Planning (SFP) began w/ Packard Foundation $$ – which is funding abortion pill studies/ publications. SFP funding study- granted UC Davis $401,764. https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/FTtWWM90gm

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

7/ Creinin, deputy editor SFP’s journal Contraception, publishes Packard-funded reports promoting self-managed abortion. Funds Gynuity which sponsors abortion pill expansion studies https://www.liveaction.org/news/exposed-conflicts-interest-abortion-pill/  more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/CarYNczMXg

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

8/ Packard’s investment seeded abortion pill MFG, DANCO including a $14 million loan as early as 1996 to bring drug RU486 (Mifepristone) to US Packard funds UC Davis sponsor of study https://www.liveaction.org/news/secrecy-abortion-pill-maker-investors/  More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/SYzUaTfwHV

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

9/ Creinin is Principal Investigator (PI) in another clinical trial by abortionist on pharmacy dispension of abortion pill https://www.liveaction.org/news/this-abortionist-claims-abortion-pill-doesnt-need-regulations-hes-wrong/ 
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

10/ Creinin previous medical/lab director Planned Parenthood of Western Pennsylvania – and an abortionist involved in original clinical trials of RU-486 abortion pill

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

11/ In summary- FOLLOW THE MONEY – something this @VICE report FAILED to do – https://news.vice.com/en_us/article/j5wqqp/theres-no-proof-abortion-reversals-are-real-this-study-could-end-the-debate 
These abortion “studies” are tied together by $$ from / Danco support from

There’s no proof “abortion reversals” are real. This study could end the debate.

Four states already mandate that doctors advise women their abortions can be reversed.

news.vice.com

See Carole Novielli’s other Tweets

As shown in the Twitter thread above, Creinin serves as consultant for abortion pill (Mifeprex) manufacturer, Danco, and receives consulting fees and compensation from the company. In addition, he receives honorarium from Danco. Creinin also provides “third-party telephone consults” for Danco. Creinin’s study sponsor is financed by the Packard Foundation, one of Danco’s major financial investors.

If this all weren’t enough to show a major conflict of interest, Creinin is also a founding member of the Society of Family Planning, which is collaborating on the study. This organization’s mission is to support abortion research, it, too, is funded by the Packard Foundation. Creinin is also the deputy editor of SFP’s official journalContraceptionPackard-funded studies in this journal unsurprisingly support the pro-abortion cause, claiming self-managed abortion is safe, and urging the undoing of current FDA safety standards restricting dispensation of the abortion pill (known as REMS). The Journal’s editorial board has been stacked with abortion industry insiders, including a National Abortion Federation board member and members of the Population Council (responsible for bringing the abortion pill into the US and forming DANCO, the manufacturer of the pill).  Obviously, the journal is pro-abortion.

Creinin is also the principal investigator in another clinical trial run abortionist/researcher Daniel Grossman (professor at University of California, San Francisco) on pharmacy dispension of the abortion pill.

Despite the fact that this conflict exists between the study’s “investigator” and Danco, media outlets ignore it. Such was the case over at Vice, which published the latest attack against abortion pill reversal, highlighting Creinin’s study without drawing one line to his connections to the abortion pill’s manufacturer. Vice headlined their hit piece: “THERE’S NO PROOF ‘ABORTION REVERSALS’ ARE REAL. THIS STUDY COULD END THE DEBATE,” in spite of the fact that Creinin’s study is only at the recruiting stage, and hasn’t reached any conclusions yet.

Or has it?

Creinin makes no secret that he doesn’t believe in abortion pill reversal  — and his profitable relationship with Danco should give any critically thinking person reason to question the motivations behind this push to “test” the effectiveness of the abortion pill reversal protocol.

    • This article is reprinted with permission. The original appeared here at Live Action News.